2135 Stock Overview
An investment holding company, provides aesthetic medical services. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Raily Aesthetic Medicine International Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.11 |
| 52 Week High | HK$0.63 |
| 52 Week Low | HK$0.087 |
| Beta | 0.97 |
| 1 Month Change | -7.69% |
| 3 Month Change | 0.93% |
| 1 Year Change | -74.88% |
| 3 Year Change | -92.42% |
| 5 Year Change | n/a |
| Change since IPO | -95.03% |
Recent News & Updates
Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Held Back By Insufficient Growth Even After Shares Climb 37%
Oct 02
Benign Growth For Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Underpins Its Share Price
Jul 22Revenues Working Against Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Share Price Following 47% Dive
Apr 22Recent updates
Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Held Back By Insufficient Growth Even After Shares Climb 37%
Oct 02Benign Growth For Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Underpins Its Share Price
Jul 22Revenues Working Against Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Share Price Following 47% Dive
Apr 22Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Stock Rockets 39% As Investors Are Less Pessimistic Than Expected
Feb 07Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Popularity With Investors Is Under Threat From Overpricing
Dec 19Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Investors Are Less Pessimistic Than Expected
Aug 22Statutory Profit Doesn't Reflect How Good Raily Aesthetic Medicine International Holdings' (HKG:2135) Earnings Are
Sep 17Shareholder Returns
| 2135 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | -0.9% | 0.2% | 1.5% |
| 1Y | -74.9% | -16.9% | 20.6% |
Return vs Industry: 2135 underperformed the Hong Kong Healthcare industry which returned -16.6% over the past year.
Return vs Market: 2135 underperformed the Hong Kong Market which returned 22.4% over the past year.
Price Volatility
| 2135 volatility | |
|---|---|
| 2135 Average Weekly Movement | 20.5% |
| Healthcare Industry Average Movement | 8.2% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in HK Market | 18.6% |
| 10% least volatile stocks in HK Market | 4.0% |
Stable Share Price: 2135's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2135's weekly volatility has increased from 14% to 21% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 321 | Jianliang Song | www.raily.com |
Raily Aesthetic Medicine International Holdings Limited, an investment holding company, provides aesthetic medical services. The company operates through three segments: Aesthetic Medical Services, Consulting Services, and Aesthetic Medical Equipment Products. Its services include aesthetic surgery services, including aesthetic surgical procedures performed on various parts of the face or body; minimally invasive aesthetic services, primarily comprising aesthetic injection procedures; aesthetic dermatology services, such as various aesthetic energy-based procedures; and aesthetic medical management consulting services.
Raily Aesthetic Medicine International Holdings Limited Fundamentals Summary
| 2135 fundamental statistics | |
|---|---|
| Market cap | HK$60.16m |
| Earnings (TTM) | -HK$33.86m |
| Revenue (TTM) | HK$222.72m |
0.3x
P/S Ratio-1.8x
P/E RatioIs 2135 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2135 income statement (TTM) | |
|---|---|
| Revenue | CN¥209.28m |
| Cost of Revenue | CN¥128.35m |
| Gross Profit | CN¥80.93m |
| Other Expenses | CN¥112.75m |
| Earnings | -CN¥31.82m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.057 |
| Gross Margin | 38.67% |
| Net Profit Margin | -15.20% |
| Debt/Equity Ratio | 10.0% |
How did 2135 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 07:45 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Raily Aesthetic Medicine International Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|